Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Outset Medical (OM) EPS (Weighted Average and Diluted) (2020 - 2026)

Outset Medical has reported EPS (Weighted Average and Diluted) over the past 6 years, most recently at -$1.0 for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 86.21% to -$1.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$6.7 through Dec 2025, up 81.89% year-over-year, with the annual reading at -$5.37 for FY2025, 85.47% up from the prior year.
  • EPS (Weighted Average and Diluted) was -$1.0 for Q4 2025 at Outset Medical, roughly flat from -$1.0 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at -$0.65 in Q3 2021 and troughed at -$49.56 in Q4 2023.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.93 (2021), against an average of -$5.12.
  • Year-over-year, EPS (Weighted Average and Diluted) soared 99.95% in 2021 and then plummeted 5800.0% in 2023.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.93 in 2021, then increased by 9.68% to -$0.84 in 2022, then crashed by 5800.0% to -$49.56 in 2023, then surged by 85.37% to -$7.25 in 2024, then soared by 86.21% to -$1.0 in 2025.
  • Per Business Quant, the three most recent readings for OM's EPS (Weighted Average and Diluted) are -$1.0 (Q4 2025), -$1.0 (Q3 2025), and -$1.04 (Q2 2025).